Literature DB >> 8059598

Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population.

P Giannakopoulos1, P R Hof, S Mottier, J P Michel, C Bouras.   

Abstract

To examine the neuropathological and clinical characteristics of cerebral aging, we evaluated retrospectively a non-selected autopsy population of 1258 patients from the Geriatric Hospital of the University of Geneva School of Medicine. The prevalence of Alzheimer's disease increased with age below 90 years of age. In the nonagenarians and centenarians, there was a decline in the number of affected cases. The distribution with age of neurofibrillary tangles and senile plaques varied among the cortical areas studied. The CA1 field of the hippocampus and the inferior temporal cortex displayed increasing densities of neurofibrillary tangles with age, whereas the superior frontal and the occipital cortex were relatively spared, especially in patients in their tenth and eleventh decade. The percentage of cases presenting with senile plaques in the neocortex and hippocampal structure increased with age with a marked predominance of cases with moderate to high senile plaque densities. Neurofibrillary tangles were often observed in the CA1 field and the inferior temporal cortex of non-demented individuals and were present in most cases with Alzheimer's disease. Conversely, the involvement of the superior frontal and occipital cortex was moderate even in demented patients. The distribution of senile plaques was homogeneous in all of the neocortical areas independently of the clinical diagnosis. Moreover, there was no correlation between the presence of neurofibrillary tangles and senile plaques in the cerebral regions studied. These results indicate a differential topography of neurofibrillary tangles and senile plaques, and suggest that overt clinical signs of Alzheimer's disease are linked to the progression of the neurodegenerative process in neocortical areas.

Entities:  

Mesh:

Year:  1994        PMID: 8059598     DOI: 10.1007/bf00294172

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  66 in total

1.  Neuropathological background of twenty-seven centenarian brains.

Authors:  T Mizutani; H Shimada
Journal:  J Neurol Sci       Date:  1992-04       Impact factor: 3.181

Review 2.  Cognitive impairment: dementia and Alzheimer's disease.

Authors:  E B Larson; W A Kukull; R L Katzman
Journal:  Annu Rev Public Health       Date:  1992       Impact factor: 21.981

3.  The EURODEM collaborative re-analysis of case-control studies of Alzheimer's disease: implications for public health.

Authors:  C Brayne
Journal:  Int J Epidemiol       Date:  1991       Impact factor: 7.196

4.  Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes.

Authors:  C Bouras; P R Hof; J H Morrison
Journal:  Neurosci Lett       Date:  1993-04-30       Impact factor: 3.046

5.  Severe dementia. Prevalence and clinical features in a biracial US population.

Authors:  B S Schoenberg; D W Anderson; A F Haerer
Journal:  Arch Neurol       Date:  1985-08

6.  A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques.

Authors:  D M Mann; A M Brown; D Prinja; D Jones; C A Davies
Journal:  Neuropathol Appl Neurobiol       Date:  1990-02       Impact factor: 8.090

7.  A case-control study of Alzheimer's disease in Australia.

Authors:  G A Broe; A S Henderson; H Creasey; E McCusker; A E Korten; A F Jorm; W Longley; J C Anthony
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

8.  A quantitative histological study of early clinical and preclinical Alzheimer's disease.

Authors:  B M Hubbard; G W Fenton; J M Anderson
Journal:  Neuropathol Appl Neurobiol       Date:  1990-04       Impact factor: 8.090

9.  Senile dementia of the Alzheimer type in the Lundby Study. I. A prospective, epidemiological study of incidence and risk during the 15 years 1957-1972.

Authors:  O Hagnell; A Franck; A Gräsbeck; R Ohman; L Ojesjö; L Otterbeck; B Rorsman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

10.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

View more
  18 in total

1.  Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old.

Authors:  John L Robinson; Felix Geser; Maria M Corrada; Daniel J Berlau; Steven E Arnold; Virginia M-Y Lee; Claudia H Kawas; John Q Trojanowski
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

2.  What does it take to stay healthy past 100?: Commentary on "No disease in the brain of a 115-year-old woman".

Authors:  Joseph L Price
Journal:  Neurobiol Aging       Date:  2008-06-04       Impact factor: 4.673

3.  Multimodality imaging characteristics of dementia with Lewy bodies.

Authors:  Kejal Kantarci; Val J Lowe; Bradley F Boeve; Stephen D Weigand; Matthew L Senjem; Scott A Przybelski; Dennis W Dickson; Joseph E Parisi; David S Knopman; Glenn E Smith; Tanis J Ferman; Ronald C Petersen; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

Review 4.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.

Authors:  Lisa Mosconi; Valentina Berti; Lidia Glodzik; Alberto Pupi; Susan De Santi; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol.

Authors:  Liana G Apostolova; Chris Zarow; Kristina Biado; Sona Hurtz; Marina Boccardi; Johanne Somme; Hedieh Honarpisheh; Anna E Blanken; Jenny Brook; Spencer Tung; Darrick Lo; Denise Ng; Jeffry R Alger; Harry V Vinters; Martina Bocchetta; Henri Duvernoy; Clifford R Jack; Giovanni B Frisoni
Journal:  Alzheimers Dement       Date:  2015-01-22       Impact factor: 21.566

Review 6.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

Review 7.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET.

Authors:  Giuseppe Esposito; Giampiero Giovacchini; Jeih-San Liow; Abesh K Bhattacharjee; Dede Greenstein; Mark Schapiro; Mark Hallett; Peter Herscovitch; William C Eckelman; Richard E Carson; Stanley I Rapoport
Journal:  J Nucl Med       Date:  2008-08-14       Impact factor: 10.057

9.  Evidence of neuronal oxidative damage in Alzheimer's disease.

Authors:  P F Good; P Werner; A Hsu; C W Olanow; D P Perl
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

10.  Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.

Authors:  Rachel Mistur; Lisa Mosconi; Susan De Santi; Marla Guzman; Yi Li; Wai Tsui; Mony J de Leon
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.